Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Investors

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.

Minimum 15 minutes delayed. Source: LSEG

Show all

Latest Results | Q3 2026

  • Earnings Release

Events

01 Dec 2026 10:00 AM AEDT
General Meeting of Shareholders
03 Nov 2026 from 5:00 PM to 8:00 PM EST
Capital Markets Day
22 Sep 2026 from 8:30 AM to 12:30 PM EDT
Telix 2026 R&D Day 2026 (New York City)
20 Sep 2026 7:30 PM EDT
Telix Pharmaceuticals Limited Investor Conference Call
15 Sep 2026 10:30 AM EDT
H.C. Wainwright 28th Annual Global Investment Conference
  • All Events

 

Presentations

Telix R&D Day Investor Presentation
  • All Presentations

News

30 Oct 2026
Telix Notice of General Meeting, Proxy Form and Online Guide
28 Oct 2026
Application for quotation of securities - TLX
27 Oct 2026
Appendix 3Y Dr Christian Behrenbruch
26 Oct 2026
Appendix 3Y William Jellison
26 Oct 2026
Appendix 3Y Change in Director Interest - D Gill
  • All News Releases

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors